We derive equilibrium incentives to use comparative advertising that pushes up own brand perception and pulls down the … matrices identify diversion ratios, from which we derive comparative advertising damage measures. We find that comparative … advertising causes more damage to the targeted rival than benefit to the advertiser. We simulate banning comparative advertising …

We estimate a model of drug demand and supply that incorporates insurance, advertising, and competition between branded …

significant effects of changes in retail prices on per capita dispensation. Moreover, firm-level analysis reveals that advertising …

significant effects of changes in retail prices on per capita dispensation. Moreover, firm-level analysis reveals that advertising …

branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …

. Advertising expenses of opioid producers increase following negative opium price shock and so do their stock prices and profits …

prescription pharmaceuticals dispensed in hospitals, physician/clinic outpatient facilities, and nursing homes. Thus the CPI …-Rx overlooks the increasingly important specialty pharmaceuticals dispensed in hospitals, outpatient clinics, and physician offices … drug growth differs from that of traditional pharmaceuticals, the CPI-Rx could provide an inaccurate measure of overall …

benefit management on behalf of insurance plans serves these and other purposes in both monopoly and oligopoly provider …